Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan
- 30 April 1999
- journal article
- clinical trial
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 25 (2), 179-185
- https://doi.org/10.1053/ejso.1998.0623
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver.Journal of Clinical Oncology, 1998
- Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumorsThe American Journal of Surgery, 1997
- Isolated Liver Perfusion with Mitomycin C in the Treatment of Colorectal Cancer Metastases Confined to the LiverJapanese Journal of Clinical Oncology, 1996
- Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.Journal of Clinical Oncology, 1996
- Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Isolated hyperthermic liver perfusion with chemotherapy for liver malignancySurgical Oncology, 1994
- Detection of Tumour Necrosis Factor from Lipopolysaccharide‐Stimulated Human Mononuclear Cells by Enzyme‐Linked Immunosorbent Assay and Cytotoxicity BioassayScandinavian Journal of Immunology, 1988
- Venous Bypass in Clinical Liver TransplantationAnnals of Surgery, 1984
- Comparison of in vitro cell cytotoxic assays for tumor necrosis factorJournal of Immunological Methods, 1984
- First Experimental and Clinical Results of Isolated Liver Perfusion with Cytotoxics in Metastases from Colorectal PrimaryPublished by Springer Nature ,1983